Loading…
Loading…
MANE (Veradermics, Incorporated) is a recent IPO.
It began trading on February 4, 2026, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
| TVTX | Travere Therapeutics, Inc. | $66.42 | $6.2B |
| HELP | Cybin Inc. Common Stock | $13.63 | $844.8M |
| OVID | Ovid Therapeutics Inc. | $2.73 | $510.3M |
| ABEO | Abeona Therapeutics Inc. | $5.85 | $333.4M |
| THAR | Tharimmune, Inc. | $3.54 | $139.9M |
| PLYX | Polaryx Therapeutics, Inc. Common Stock | $2.04 | $101.7M |
| LSTA | Lisata Therapeutics, Inc. | $1.95 | $17.8M |
| ADIL | Adial Pharmaceuticals, Inc. | $6.22 | $6.0M |
| XTLB | XTL Biopharmaceuticals Ltd. | $2.51 | $2.4M |
| DRMA | Dermata Therapeutics, Inc. | $1.24 | $845.1K |